Subscribe To

Price Alert Latest News Economic Calendar News

VREX / Varex Imaging Corporation (VREX) Q4 2022 Earnings Call Transcript

Varex Imaging Corporation (NASDAQ:VREX ) Q4 2022 Earnings Conference Call November 15, 2022 5:00 PM ET Company Participants Christopher Belfiore - Director of Investor Relations Sunny Sanyal - President & Chief Executive Officer Sam Maheshwari - Chief Financial Officer Conference Call Participants Larry Solow - CJS Suraj Kalia - Oppenheimer Anthony Petrone - Mizuho Group Jim Sidoti - Sidoti & Company Operator Hello and welcome to the Varex Fourth Quarter Fiscal Year 2022 Earnings Call. At this time, all participants are in listen-only mode. Read More

Demo Live Account See Partner Details

Content Topics

Varex

Imaging

Corporation

VREX

2022

Earnings

Call

vrex

Transcript

Stock

Posted: Nov 15 2022, 21:00

Author Name: Seeking Alpha

VREX News

By Business Wire
September 11, 2023

Varex to Present at the Sidoti Small Cap Virtual Conference

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Sidoti Small

By Seeking Alpha
August 1, 2023

Varex Imaging Corporation (VREX) Q3 2023 Earnings Call Transcript

Varex Imaging Corporation (NASDAQ:VREX ) Q3 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Christopher Belfiore - Invest

By Zacks Investment Research
August 1, 2023

VAREX IMAGING (VREX) Surpasses Q3 Earnings and Revenue Estimates

VAREX IMAGING (VREX) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to ea

By Business Wire
July 18, 2023

Varex Schedules Third Quarter Fiscal Year 2023 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the thir

By Zacks Investment Research
May 23, 2023

VREX vs. ESLOY: Which Stock Should Value Investors Buy Now?

Investors interested in Medical - Products stocks are likely familiar with VAREX IMAGING (VREX) and EssilorLuxottica Unsponsored ADR (ESLOY). But whic

By Zacks Investment Research
May 11, 2023

Add These 5 Low Price-to-Book Stocks to Your Portfolio in May

The P/B ratio helps to identify low-priced stocks that have high growth prospects. Deutsche Bank (DB), General Motors (GM), Unum Group (UNM), PVH Corp

By Zacks Investment Research
May 9, 2023

Here's Why VAREX IMAGING (VREX) is a Great Momentum Stock to Buy

Does VAREX IMAGING (VREX) have what it takes to be a top stock pick for momentum investors? Let's find out.

By Zacks Investment Research
May 5, 2023

VAREX IMAGING (VREX) Upgraded to Strong Buy: Here's What You Should Know

VAREX IMAGING (VREX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.